Breaking News Instant updates and real-time market news.

CRHM

CRH Medical

$5.20

-0.05 (-0.95%)

07:29
07/14/17
07/14
07:29
07/14/17
07:29

CRH Medical downgraded to Sector Perform from Outperform at Scotiabank

CRHM CRH Medical
$5.20

-0.05 (-0.95%)

04/27/17
ADAM
04/27/17
NO CHANGE
Target $9
ADAM
Buy
Now is a great time to build a position in CRH Medical, says Canaccord
Canaccord analyst Richard Close noted CRH Medical beat Q1 estimates driven by strong volumes in Anesthesia Services and better than expected margins, adding that the report is the first step in dispelling investor fears. He said with shares down 27% since last week, now is a great time to build a position. Close reiterated his Buy rating and $9 price target on CRH Medical shares.
04/25/17
ADAM
04/25/17
NO CHANGE
Target $9
ADAM
Buy
CRH Medical selloff overdone, says Canaccord
Canaccord analyst Richard Close said the 25% pullback in CRH Medical shares is overdone and the shares offer an intriguing entry point. He said CRH shares fell on concerns over reimbursement risk, but the analyst argues that is the case with nearly all healthcare services companies. He said other areas of concern include pricing risk after acquisitions, but he does not believe either of those risks pose an immediate or significant risk to his long-term thesis. Close maintained his Buy rating and $9 price target on CRH Medical shares.
04/24/17
04/24/17
NO CHANGE
Target $10

Overweight
Cantor discusses recent selloff in CRH Medical
Cantor Fitzgerald analyst Joseph France earlier today attributed Friday's 20% selloff in shares of CRH Medical to a week-old short investor letter, which questioned the company's business model and outlook for reimbursement. CRH today is down another 21% to $5.80. The company has the risks of any rollup, but its model works because it improves the administrative and clinical practice of ASC gastroenterology, France told investors this morning in a research note. The analyst believes no new issues have been raised for CRH and he views the stock's selloff as overdone. France has an Overweight rating on the shares with a $10 price target.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.